KPTI: Karyopharm Therapeutics Inc. Stock

by  •  • Comments Off on KPTI: Karyopharm Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 76.98
Enterprise Value ($M) 275.37
Book Value ($M) -186.02
Book Value / Share -1.47
Price / Book -0.41
NCAV ($M) -193.94
NCAV / Share -1.54
Price / NCAV -0.40

Profitability (mra)
Return on Invested Capital (ROIC) -0.93
Return on Assets (ROA) -0.32
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.64
Current Ratio 1.70

Balance Sheet (mrq) ($M)
Current Assets 156.49
Assets 164.42
Liabilities 350.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 145.24
Operating Income -119.44
Net Income -76.42
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -127.49
Cash from Investing 95.47
Cash from Financing 41.65

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G Adage Capital Management, L.P.
11-14 13G/A Avidity Partners Management LP 3.70 -57.63
11-12 13G/A Vanguard Group Inc 6.13 0.00
10-25 13G Highbridge Capital Management Llc 7.20
07-08 13G/A BlackRock, Inc. 3.50 -58.60
05-23 13G J. Wood Capital Advisors Llc 5.50
2024-02-14 13G/A Palo Alto Investors LP 4.45 -9.79
2024-02-12 13G/A Rubric Capital Management LP 0.00 -100.00
2024-01-22 13G/A State Street Corp 1.79 -7.17

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 172,145 1,043,301 16.50
2025-02-20 156,218 543,074 28.77
2025-02-19 568,286 2,048,432 27.74
2025-02-18 217,546 1,025,614 21.21

(click for more detail)

Similar Companies
JAZZ – Jazz Pharmaceuticals plc KMDA – Kamada Ltd.
KNSA – Kiniksa Pharmaceuticals, Ltd. KRON – Kronos Bio, Inc.
KRYS – Krystal Biotech, Inc.


Financial data and stock pages provided by
Fintel.io